Cyril Lesser - Profile and Investment Details

Investor Profile

Cyril Lesser is a Venture Capital based in Naarden, North Holland, The Netherlands with a diverse investment portfolio that includes companies such as Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems, Borean Pharma, Roche Glycart, NovoGI, Oxyrane UK, OMEICOS Therapeutics, Inflazome, Amakem, Pulmologix, Ardana Bioscience, CoviCept Therapeutics, Rigontec, FlowMedica, Oxular, NeRRe Therapeutics, Hookipa Pharma, NorthSea Therapeutics, SANIFIT, PneumRx, Gotham Therapeutics, Catalym, Insmed, Mitralign, Prilenia, KaNDy Therapeutics, Ario Pharma, Cardoz, CircuLite, BioVex, Cytheris, Bluebird Bio, Pieris AG, UniQure, CellNovo, Akarna Therapeutics, Escalier Biosciences, Azafaros, Enterprise Therapeutics, Bioceros, Replimune Group, Exosome Diagnostics, Acorda Therapeutics, Dyne Therapeutics, gIcare Pharma, Amphista Therapeutics, Milestone Pharmaceuticals, Dezima Pharma, Fovea Pharmaceuticals, Inversago Pharma, Gyroscope Therapeutics, New Amsterdam Pharma, Autonomic Technologies, Xention, Achilles Therapeutics, arGEN-X, Curetis, ACADIA Pharmaceuticals, Allecra Therapeutics, PanGenetics, Promedior, Transave, Argos Therapeutics, enGene, Prexton Therapeutics. Over time, Cyril Lesser has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Cyril Lesser is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Medical Testing, Life Science, Biotech, Healthcare, Biotechnology, Genomics, Health Diagnostics, Medical, Therapeutics, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Cyril Lesser, as their portfolio suggests a familiarity and interest in this area.

Understanding Cyril Lesser’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.